Shared on08 May 25Fair value Increased 3.69%
AnalystLowTarget has decreased revenue growth from 2.4% to 1.9%.
Escalating PFAS Liabilities And Cost Pressures Will Weigh Future Prospects
AnalystLowTarget's Fair Value
US$11.41
34.8% overvalued intrinsic discount20 Aug
US$15.37
1Y
-20.4%7D
5.1%